Skip to content
Biolazar
senolyticEmerging

Quercetin (with bromelain)

Flavonoid with anti-inflammatory and senolytic properties (studied alongside dasatinib). Poor oral bioavailability.

Dosage

500–1,000 mg/day. Bromelain or lipid-based formulations improve absorption.

Considerations

Senolytic effect in humans shown primarily in combination with dasatinib — mono-quercetin effects unclear.

Where to buy

Affiliate link — we may earn a commission at no extra cost to you.